An Advanced Decision Support Tool, Opt-IVF for Clinical Ivf Practice

NCT05564702 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2023-04-28

No results posted yet for this study

Summary

Aim: A Clinical trial to determine the effectiveness of using the proposed decision support tool for each patient's customized optimal drug dosage profile. This will be a two-arm clinical trial involving 200 patients; one arm will undergo superovulation using dosages predicted by the decision support tool while the other arm will undergo current standard treatment. The investigators will compare the outcomes of the two groups of patients in terms of the numbers and percentage of mature follicles retrieved at the end of each cycle, total FSH and HMG dosages used, and the number of required testing days for that cycle. The patients considered will include all ages, with and without PCOS, and low, average, and high responders.

Conditions

Interventions

OTHER

traditional drug treatment

The patients in this arm will be given doctor specified dosage.

OTHER

Opt-IVF predicted dosage

The patients in this arm will be given dosage predicted by Opt-IVF.

Sponsors & Collaborators

  • Akansha Hospital and Research Institute, India

    collaborator UNKNOWN
  • Stochastic Research Technologies LLC

    lead INDUSTRY

Principal Investigators

  • Urmila Diwekar · Stochastic Research Technologies LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-08
Primary Completion
2023-03-15
Completion
2023-03-15

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05564702 on ClinicalTrials.gov